June 2026 Quarterly Activities Report & Appendix 4C
Filed with ASX · · 9 pages · English
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- Positive interim analysis advances Avecho Phase III insomnia program
- Positive interim results from Phase III insomnia program
- Receipt of Research & Development Tax Incentive
- Avecho completes treatment for Phase III interim analysis
- Expiry of Listed Options
Later from Avecho Biotechnology
- Avecho enters final stage of Phase III insomnia trial
- Response to ASX Price Query
- September 2026 Quarterly Activities Report & Appendix 4C
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology